Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Chicago, Illinois 60637


Purpose:

The purpose of this study is to determine the effectiveness of a particular combination of drugs used to treat cancer.


Criteria:

Inclusion Criteria: - Patients must have received cytotoxic chemotherapy,radiation,or a drug known to affect the properties of DNA or cell growth for some condition other than acute myeloid leukemia prior to diagnosis. - Patients must have t-MDS/t-AML - To be eligible for allogeneic transplantation, patients must have a suitable donor who is HLA compatible. - Patients must be over the age of 10. - Patients must be reviewed and discussed at the Leukemia and Transplant Conferences of the Section of Hematology/Oncology. Exclusion Criteria: - Patients must not have any other serious medical condition(e.g.uncontrolled or severe cardiovascular disease, diabetes, pulmonary disease, or infection) - Psychiatric condition which would prevent compliance or possibly be worsened by treatment


NCT ID:

NCT00774046


Primary Contact:

Principal Investigator
Lucy Godley, M.D.
University of Chicago


Backup Contact:

N/A


Location Contact:

Chicago, Illinois 60637
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.